Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard?
- 1 April 1995
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 33 (4) , 1001-1004
- https://doi.org/10.1128/jcm.33.4.1001-1004.1995
Abstract
An environmental survey of 55 sites yielded only 12 Burkholderia cepacia isolates, none of which displayed the phenotypic properties of a multiresistant epidemic strain associated with pulmonary colonization in patients with cystic fibrosis. Although the environment probably poses a low risk for patients with cystic fibrosis as a source of B. cepacia, the pathogenic potential of individual environmental strains remains unclear. We advise caution in the development of B. cepacia as a biocontrol agent.Keywords
This publication has 27 references indexed in Scilit:
- Serum sensitivity ofBurkholderia(Pseudomonas)cepaciaisolates from patients with cystic fibrosisFEMS Immunology & Medical Microbiology, 1994
- Source of Pseudomonas cepacia: Ribotyping of isolates from patients and from the environmentThe Journal of Pediatrics, 1993
- Cystic fibrosis in the mouse by targeted insertional mutagenesisNature, 1992
- The identification ofPseudomonas cepaciaand its occurrence in clinical materialJournal of Applied Bacteriology, 1986
- Pseudomonas cepacia: An emerging pathogen in chronic granulomatous diseaseThe Journal of Pediatrics, 1986
- Antibiotic resistance of Pseudomonas speciesPublished by Elsevier ,1986
- Pseudomonas cepacia infection in cystic fibrosis: An emerging problemThe Journal of Pediatrics, 1984
- Bacteriocin, Plasmid and Pectolytic Diversity in Pseudomonas cepacia of Clinical and Plant OriginJournal of General Microbiology, 1979
- FOOT LESIONS ASSOCIATED WITH PSEUDOMONAS CEPACIAThe Lancet, 1971
- Taxonomy of the Aerobic Pseudomonads: Pseudomonas cepacia, P. marginata, P. alliicola and P. caryophylliJournal of General Microbiology, 1970